Cite

HARVARD Citation

    Logan, J. et al. (2021). Survival Outcomes of Nonsmall Cell Lung Cancer Patients Treated with Afatinib Who Are Affected by Early Adverse Events. Journal of oncology. p. . [Online]. 
  
Back to record